Orexigen Therapeutics (OREX)
Create an Alert
6.33
-0.05 -0.78%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Pro Data Export
Orexigen Therapeutics Key Statistics
Currency in USD
Current Valuation
Dividends and Shares
| Shares Outstanding | 92.64M |
| Dividend | |
| Dividend Yield | 0% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -3787% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 5.530 |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 4.80% |
| Year to Date Stock Returns | 20.57% |
| 1 Year Stock Returns | 58.25% |
| 3 Year Stock Returns | 46.53% |
| 52 Week High | 7.73 |
| 52 Week Low | 3.76 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 58.27M |
| Cash from Investing TTM | -13.34M |
| Cash from Operations TTM | -68.34M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 137.40M |
| Long Term Debt | 0.00 |
| Total Assets | 139.15M |
| Liabilities | 63.68M |
| Shareholders Equity | 75.47M |
| Book Value | 75.47M |
| Book Value Per Share | 0.8146 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
OREX News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OREX | 6.33 | -0.05 | -0.78% | 586.42M |
